Imat 400 mg Tablet
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Imat 400 mg Tablet

Imat 400 mg Tablet

Imat 400 mg Tablet contains imatinib mesylate, a targeted anticancer medicine used to treat certain blood cancers and gastrointestinal stromal tumors. It contains 400 mg of imatinib and is taken orally according to the prescribed treatment regimen. Imatinib blocks specific tyrosine kinases that promote abnormal cancer-cell growth.

BUY NOW

Category

Imat 400 mg Tablet is used for conditions such as chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, and gastrointestinal stromal tumors. It may also be prescribed for selected conditions including dermatofibrosarcoma protuberans and certain myeloproliferative disorders. Imatinib inhibits abnormal signaling proteins such as BCR-ABL and KIT, helping control the growth of malignant cells. The tablet should be taken consistently as directed by the treating specialist, with appropriate monitoring during therapy.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer/Marketer Zydus Healthcare Limited

Product Also Known As

Imat 400 mg Tablet, Imat 400 Tablet, Imatinib 400 mg Tablet, Imatinib Mesylate 400 mg Tablet, Imat Imatinib Tablet, BCR-ABL Tyrosine Kinase Inhibitor Tablet